GH GUARDANT HEALTH INC More: the full row for GUARDANT HEALTH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,419,566 shares; 2025Q1: 5,443,721 shares; 2025Q2: 4,250,000 shares; 2025Q3: 4,154,086 shares; 2025Q4: 2,800,000 shares; 2026Q1: 3,338,241 shares; 2026Q2: 3,393,312 shares; 2026Q3: 2,805,677 shares 2,805,677 $500M 8.42% -587,635 Timeline BMRN BIOMARIN PHARMACEUTICAL INC More: the full row for BIOMARIN PHARMACEUTICAL INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 24,856 shares; 2025Q4: 2,300,000 shares; 2026Q1: 1,150,000 shares; 2026Q2: 3,307,481 shares; 2026Q3: 6,374,395 shares 6,374,395 $382M 6.44% +3,066,914 Timeline IMVT IMMUNOVANT INC More: the full row for IMMUNOVANT INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,000,000 shares; 2025Q1: 9,500,000 shares; 2025Q2: 9,500,000 shares; 2025Q3: 9,728,845 shares; 2025Q4: 11,526,971 shares; 2026Q1: 11,526,971 shares; 2026Q2: 9,341,151 shares; 2026Q3: 9,160,801 shares 9,160,801 $309M 5.21% -180,350 Timeline TARS TARSUS PHARMACEUTICALS INC More: the full row for TARSUS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,484,266 shares; 2025Q2: 1,750,000 shares; 2025Q3: 3,000,000 shares; 2025Q4: 3,004,034 shares; 2026Q1: 3,600,000 shares; 2026Q2: 3,666,768 shares; 2026Q3: 3,806,768 shares 3,806,768 $299M 5.04% +140,000 Timeline MANE VERADERMICS INC More: the full row for VERADERMICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 500,000 shares; 2026Q2: 2,000,000 shares; 2026Q3: 1,900,000 shares 1,900,000 $230M 3.88% -100,000 Timeline VERA VERA THERAPEUTICS INC More: the full row for VERA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,821,135 shares; 2026Q1: 4,106,067 shares; 2026Q2: 4,000,000 shares; 2026Q3: 7,000,000 shares 7,000,000 $226M 3.8% +3,000,000 Timeline PCVX VAXCYTE INC More: the full row for VAXCYTE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 750,000 shares; 2025Q2: 2,150,000 shares; 2025Q3: 3,000,000 shares; 2025Q4: 4,000,000 shares; 2026Q1: 4,300,000 shares; 2026Q2: 4,300,000 shares; 2026Q3: 3,513,069 shares 3,513,069 $200M 3.36% -786,931 Timeline ALKS ALKERMES PLC More: the full row for ALKERMES PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,000,000 shares; 2026Q1: 3,590,323 shares; 2026Q2: 4,000,000 shares; 2026Q3: 4,500,000 shares 4,500,000 $182M 3.07% +500,000 Timeline OCUL OCULAR THERAPEUTIX INC More: the full row for OCULAR THERAPEUTIX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 12,836,282 shares; 2025Q1: 14,294,420 shares; 2025Q2: 14,294,420 shares; 2025Q3: 11,932,137 shares; 2025Q4: 8,070,414 shares; 2026Q1: 19,686,282 shares; 2026Q2: 19,686,282 shares; 2026Q3: 21,939,625 shares 21,939,625 $168M 2.83% +2,253,343 Timeline UTHR UNITED THERAPEUTICS CORP DEL More: the full row for UNITED THERAPEUTICS CORP DEL Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 123,616 shares; 2026Q3: 300,040 shares 300,040 $163M 2.74% +176,424 Timeline GPCR STRUCTURE THERAPEUTICS INC More: the full row for STRUCTURE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,800,000 shares; 2025Q1: 4,100,000 shares; 2025Q2: 5,133,917 shares; 2025Q3: 4,215,811 shares; 2025Q4: 4,111,782 shares; 2026Q1: 4,279,848 shares; 2026Q2: 4,740,072 shares; 2026Q3: 5,000,000 shares 5,000,000 $156M 2.63% +259,928 Timeline GRAL GRAIL INC More: the full row for GRAIL INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,022,797 shares; 2026Q1: 1,722,797 shares; 2026Q2: 1,834,944 shares; 2026Q3: 1,104,200 shares 1,104,200 $155M 2.6% -730,744 Timeline INSM INSMED INC More: the full row for INSMED INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 254,751 shares; 2025Q2: 1,750,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,350,000 shares 1,350,000 $154M 2.59% new Timeline CMPS COMPASS PATHWAYS PLC More: the full row for COMPASS PATHWAYS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 8,859,648 shares; 2025Q2: 8,831,007 shares; 2025Q3: 7,859,648 shares; 2025Q4: 7,334,323 shares; 2026Q1: 12,161,496 shares; 2026Q2: 12,161,496 shares; 2026Q3: 12,161,496 shares 12,161,496 $151M 2.55% 0 Timeline GMAB GENMAB A/S More: the full row for GENMAB A/S Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,000,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 481,267 shares; 2025Q4: not reported; 2026Q1: 3,663,250 shares; 2026Q2: 5,650,000 shares; 2026Q3: 4,182,689 shares 4,182,689 $149M 2.51% -1,467,311 Timeline AXSM AXSOME THERAPEUTICS INC. More: the full row for AXSOME THERAPEUTICS INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 801,371 shares; 2025Q3: 900,000 shares; 2025Q4: 1,150,000 shares; 2026Q1: 1,100,000 shares; 2026Q2: 700,000 shares; 2026Q3: 800,000 shares 800,000 $148M 2.48% +100,000 Timeline NRIX NURIX THERAPEUTICS INC More: the full row for NURIX THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,000,000 shares; 2025Q1: 5,500,000 shares; 2025Q2: 6,064,910 shares; 2025Q3: 6,057,024 shares; 2025Q4: 7,036,455 shares; 2026Q1: 6,345,244 shares; 2026Q2: 7,736,455 shares; 2026Q3: 6,000,000 shares 6,000,000 $142M 2.39% -1,736,455 Timeline LBRX LB PHARMACEUTICALS INC More: the full row for LB PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 3,352,804 shares; 2025Q4: 3,352,804 shares; 2026Q1: 3,352,804 shares; 2026Q2: 3,352,804 shares; 2026Q3: 3,352,804 shares 3,352,804 $129M 2.17% 0 Timeline TNGX TANGO THERAPEUTICS INC More: the full row for TANGO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,454,562 shares; 2025Q4: 2,454,562 shares; 2026Q1: 2,750,000 shares; 2026Q2: 4,200,000 shares; 2026Q3: 4,500,000 shares 4,500,000 $112M 1.89% +300,000 Timeline MAZE MAZE THERAPEUTICS INC More: the full row for MAZE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 3,269,126 shares; 2025Q2: 3,948,910 shares; 2025Q3: 3,948,910 shares; 2025Q4: 4,246,440 shares; 2026Q1: 3,477,562 shares; 2026Q2: 3,732,569 shares; 2026Q3: 4,083,969 shares 4,083,969 $111M 1.87% +351,400 Timeline COAG HEMAB THERAPEUTICS HLDGS INC More: the full row for HEMAB THERAPEUTICS HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,602,093 shares; 2026Q3: 3,587,796 shares 3,587,796 $111M 1.86% -14,297 Timeline MLTX MOONLAKE IMMUNOTHERAPEUTICS More: the full row for MOONLAKE IMMUNOTHERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,610,071 shares; 2026Q1: 6,408,863 shares; 2026Q2: 6,999,025 shares; 2026Q3: 8,105,290 shares 8,105,290 $94.8M 1.6% +1,106,265 Timeline ORKA ORUKA THERAPEUTICS INC More: the full row for ORUKA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 750,000 shares; 2025Q1: 1,444,709 shares; 2025Q2: 1,918,798 shares; 2025Q3: 2,654,781 shares; 2025Q4: 2,161,510 shares; 2026Q1: 2,034,203 shares; 2026Q2: 1,926,000 shares; 2026Q3: 1,069,774 shares 1,069,774 $89.1M 1.5% -856,226 Timeline WGS GENEDX HOLDINGS CORP More: the full row for GENEDX HOLDINGS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 700,000 shares; 2026Q3: 1,200,000 shares 1,200,000 $86.8M 1.46% +500,000 2026-11-10, 13G : 1,800,000 shares, 6.01% of the class, 13G filed 2026-11-17 Timeline COGT COGENT BIOSCIENCES INC More: the full row for COGENT BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 453,102 shares; 2026Q1: 1,000,000 shares; 2026Q2: 2,000,000 shares; 2026Q3: 2,500,000 shares 2,500,000 $80M 1.35% +500,000 Timeline GHRS GH RESEARCH PLC More: the full row for GH RESEARCH PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 2,000,000 shares; 2025Q2: 2,000,000 shares; 2025Q3: 1,250,000 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,333,334 shares; 2026Q3: 3,333,334 shares 3,333,334 $78.3M 1.32% 0 Timeline BCAX BICARA THERAPEUTICS INC More: the full row for BICARA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,000,000 shares; 2025Q1: 2,000,000 shares; 2025Q2: 2,426,657 shares; 2025Q3: 2,426,657 shares; 2025Q4: 2,614,004 shares; 2026Q1: 4,062,500 shares; 2026Q2: 4,100,000 shares; 2026Q3: 4,100,000 shares 4,100,000 $76.3M 1.28% 0 Timeline LTGO LATIGO BIOTHERAPEUTICS INC More: the full row for LATIGO BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 4,408,322 shares 4,408,322 $73.6M 1.24% new Timeline CLDX CELLDEX THERAPEUTICS INC NEW More: the full row for CELLDEX THERAPEUTICS INC NEW Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,540,132 shares; 2025Q1: 2,000,000 shares; 2025Q2: 2,000,000 shares; 2025Q3: 2,000,000 shares; 2025Q4: 1,900,738 shares; 2026Q1: 1,283,979 shares; 2026Q2: 2,939,151 shares; 2026Q3: 2,125,532 shares 2,125,532 $68.9M 1.16% -813,619 Timeline BBIO BRIDGEBIO PHARMA INC More: the full row for BRIDGEBIO PHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 819,162 shares; 2025Q1: 2,800,000 shares; 2025Q2: 900,000 shares; 2025Q3: 1,200,000 shares; 2025Q4: 810,142 shares; 2026Q1: 841,445 shares; 2026Q2: not reported; 2026Q3: 885,882 shares 885,882 $58.3M 0.98% new Timeline AVTX AVALO THERAPEUTICS INC More: the full row for AVALO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 867,000 shares; 2025Q1: 859,876 shares; 2025Q2: 567,103 shares; 2025Q3: 144,600 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,610,000 shares; 2026Q3: 3,610,000 shares 3,610,000 $55.3M 0.93% 0 Timeline ALMS ALUMIS INC More: the full row for ALUMIS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 6,772,595 shares; 2026Q2: 6,348,558 shares; 2026Q3: 7,469,746 shares 7,469,746 $55.2M 0.93% +1,121,188 Timeline ALT ALTIMMUNE INC More: the full row for ALTIMMUNE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 19,250,000 shares; 2026Q3: 19,250,000 shares 19,250,000 $55.1M 0.93% 0 Timeline ATTO ATTOVIA THERAPEUTICS INC More: the full row for ATTOVIA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 3,207,138 shares 3,207,138 $55M 0.93% new Timeline BLLN BILLIONTOONE INC More: the full row for BILLIONTOONE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 50,000 shares; 2026Q1: 50,000 shares; 2026Q2: not reported; 2026Q3: 500,000 shares 500,000 $53.2M 0.9% new Timeline ACRS ACLARIS THERAPEUTICS INC More: the full row for ACLARIS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 9,345,000 shares; 2026Q2: 9,345,000 shares; 2026Q3: 9,345,000 shares 9,345,000 $49.2M 0.83% 0 Timeline CRMD CORMEDIX INC More: the full row for CORMEDIX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 500,000 shares; 2025Q4: 5,274,076 shares; 2026Q1: 6,274,076 shares; 2026Q2: 6,274,076 shares; 2026Q3: 6,274,076 shares 6,274,076 $48.3M 0.81% 0 Timeline EWTX EDGEWISE THERAPEUTICS INC More: the full row for EDGEWISE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 710,421 shares; 2025Q1: 1,400,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,148,817 shares 1,148,817 $46.6M 0.78% new Timeline VSTM VERASTEM INC More: the full row for VERASTEM INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 5,740,850 shares; 2026Q1: 5,740,850 shares; 2026Q2: 5,740,850 shares; 2026Q3: 5,740,850 shares 5,740,850 $46.2M 0.78% 0 Timeline DFTX DEFINIUM THERAPEUTICS INC More: the full row for DEFINIUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,000,000 shares; 2026Q2: 2,750,000 shares; 2026Q3: 1,000,000 shares 1,000,000 $38.1M 0.64% -1,750,000 Timeline GENB GENERATE BIOMEDICINES INC More: the full row for GENERATE BIOMEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,333,815 shares; 2026Q3: 2,507,449 shares 2,507,449 $37.7M 0.63% +1,173,634 Timeline MBX MBX BIOSCIENCES INC More: the full row for MBX BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,018,935 shares; 2025Q1: 3,018,935 shares; 2025Q2: 2,188,592 shares; 2025Q3: 3,150,000 shares; 2025Q4: 3,249,790 shares; 2026Q1: 2,757,569 shares; 2026Q2: 1,732,569 shares; 2026Q3: 640,000 shares 640,000 $37.5M 0.63% -1,092,569 Timeline ANIP ANI PHARMACEUTICALS INC More: the full row for ANI PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 649,042 shares; 2025Q1: 700,000 shares; 2025Q2: 700,000 shares; 2025Q3: 450,000 shares; 2025Q4: 477,684 shares; 2026Q1: 600,000 shares; 2026Q2: not reported; 2026Q3: 500,000 shares 500,000 $36.3M 0.61% new Timeline VRDN VIRIDIAN THERAPEUTICS INC More: the full row for VIRIDIAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,522,741 shares; 2025Q1: 5,380,449 shares; 2025Q2: 5,380,449 shares; 2025Q3: 5,380,449 shares; 2025Q4: 2,524,833 shares; 2026Q1: 1,393,944 shares; 2026Q2: 3,592,740 shares; 2026Q3: 1,711,030 shares 1,711,030 $35.2M 0.59% -1,881,710 Timeline HROW HARROW INC More: the full row for HARROW INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 969,000 shares; 2026Q3: 1,069,000 shares 1,069,000 $32.9M 0.55% +100,000 Timeline OBX OBSIDIAN THERAPEUTICS INC More: the full row for OBSIDIAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,120,050 shares 2,120,050 $29.1M 0.49% new Timeline CRVS CORVUS PHARMACEUTICALS INC More: the full row for CORVUS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,491,539 shares; 2026Q2: 2,491,939 shares; 2026Q3: 2,491,939 shares 2,491,939 $28.7M 0.48% 0 Timeline NBIX NEUROCRINE BIOSCIENCES INC More: the full row for NEUROCRINE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 200,000 shares 200,000 $28.4M 0.48% new Timeline SLDB SOLID BIOSCIENCES INC More: the full row for SOLID BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,565,062 shares; 2026Q2: 3,565,062 shares; 2026Q3: 3,565,062 shares 3,565,062 $25.8M 0.43% 0 Timeline STTK SHATTUCK LABS INC More: the full row for SHATTUCK LABS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,706,734 shares; 2026Q3: 3,706,734 shares 3,706,734 $25.3M 0.43% 0 Timeline BEAM BEAM THERAPEUTICS INC More: the full row for BEAM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 315,765 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 820,765 shares; 2026Q2: 1,000,000 shares; 2026Q3: 1,000,000 shares 1,000,000 $24.4M 0.41% 0 Timeline MNKD MANNKIND CORP More: the full row for MANNKIND CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 6,000,000 shares; 2026Q3: 5,030,522 shares 5,030,522 $19.6M 0.33% -969,478 Timeline XENE XENON PHARMACEUTICALS INC More: the full row for XENON PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 169,132 shares; 2025Q1: 1,000,000 shares; 2025Q2: 1,350,000 shares; 2025Q3: 1,200,000 shares; 2025Q4: 366,435 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 500,000 shares 500,000 $18.6M 0.31% new Timeline OLMA OLEMA PHARMACEUTICALS INC More: the full row for OLEMA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,442,833 shares; 2025Q1: 3,442,833 shares; 2025Q2: 3,442,833 shares; 2025Q3: 3,470,172 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,500,000 shares; 2026Q3: 2,109,951 shares 2,109,951 $18.2M 0.31% +609,951 Timeline NKTR NEKTAR THERAPEUTICS More: the full row for NEKTAR THERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 300,000 shares; 2026Q3: 300,000 shares 300,000 $18.2M 0.31% 0 Timeline DSGN DESIGN THERAPEUTICS INC More: the full row for DESIGN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,323,986 shares 1,323,986 $16.6M 0.28% new Timeline IPSC CENTURY THERAPEUTICS INC More: the full row for CENTURY THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 9,487,745 shares; 2026Q2: 9,462,645 shares; 2026Q3: 9,462,645 shares 9,462,645 $16.2M 0.27% 0 Timeline XNCR XENCOR INC More: the full row for XENCOR INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 500,000 shares; 2025Q1: 549,439 shares; 2025Q2: 549,439 shares; 2025Q3: 549,439 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 593,551 shares; 2026Q3: 540,000 shares 540,000 $13.5M 0.23% -53,551 Timeline MPLT MAPLIGHT THERAPEUTICS INC More: the full row for MAPLIGHT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,318,101 shares 1,318,101 $13.4M 0.23% new Timeline ENTA ENANTA PHARMACEUTICALS INC More: the full row for ENANTA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,956,867 shares; 2026Q1: 1,956,867 shares; 2026Q2: 1,444,167 shares; 2026Q3: 1,000,000 shares 1,000,000 $13.2M 0.22% -444,167 Timeline XFOR X4 PHARMACEUTICALS INC More: the full row for X4 PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,122,484 shares; 2025Q4: 5,013,661 shares; 2026Q1: 6,339,535 shares; 2026Q2: 5,878,757 shares; 2026Q3: 4,501,684 shares 4,501,684 $13.1M 0.22% -1,377,073 Timeline KARD KARDIGAN INC More: the full row for KARDIGAN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 600,000 shares; 2026Q3: 600,000 shares 600,000 $8.85M 0.15% 0 Timeline PMN PROMIS NEUROSCIENCES INC More: the full row for PROMIS NEUROSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 835,655 shares; 2026Q2: 835,655 shares; 2026Q3: 740,117 shares 740,117 $8.03M 0.14% -95,538 Timeline ENTX ENTERA BIO LTD More: the full row for ENTERA BIO LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,450,980 shares 2,450,980 $7.13M 0.12% new Timeline RXST RXSIGHT INC More: the full row for RXSIGHT INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,230,566 shares 1,230,566 $6.03M 0.1% new Timeline RNAQU RAINIER ACQUISITION CORP More: the full row for RAINIER ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 500,000 shares 500,000 $5.1M 0.09% new Timeline JTTT JATT III ACQUISITION CORP More: the full row for JATT III ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 450,000 shares 450,000 $4.96M 0.08% new Timeline RACD RESEARCH ALLIANCE CORP IV More: the full row for RESEARCH ALLIANCE CORP IV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 400,000 shares 400,000 $4.63M 0.08% new Timeline TCGX TCGX ACQUISITION CORP More: the full row for TCGX ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,000 shares 300,000 $3.75M 0.06% new Timeline ALGS ALIGOS THERAPEUTICS INC More: the full row for ALIGOS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 244,110 shares; 2025Q1: 444,110 shares; 2025Q2: 444,110 shares; 2025Q3: 444,110 shares; 2025Q4: 444,110 shares; 2026Q1: 444,110 shares; 2026Q2: 444,110 shares; 2026Q3: 444,110 shares 444,110 $2.5M 0.04% 0 Timeline CNTX CONTEXT THERAPEUTICS INC More: the full row for CONTEXT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 7,419,355 shares; 2025Q1: 7,419,355 shares; 2025Q2: 7,419,355 shares; 2025Q3: 7,419,355 shares; 2025Q4: 7,419,355 shares; 2026Q1: 7,419,355 shares; 2026Q2: 7,419,355 shares; 2026Q3: 7,419,355 shares 7,419,355 $2.23M 0.04% 0 Timeline